← All trials
NCT05476107
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 26, 2021
- Primary completion
- Mar 26, 2022
- Completion date
- Mar 26, 2022
- First posted
- Jul 27, 2022
- Last posted
- Jul 27, 2022
- Enrollment
- 50
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Applied Molecular TransportLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.